Showing 501 - 520 results of 100,181 for search '(( 5 ((((ppm decrease) OR (a decrease))) OR (mean decrease)) ) OR ( 5 ht decrease ))', query time: 1.32s Refine Results
  1. 501
  2. 502
  3. 503

    Anatomical confirmation of drug injection sites. by Diana Amorim (662998)

    Published 2015
    “…<p>Schematic representation of the injection sites in the dorsomedial nucleus of the hypothalamus (DMH) (<b>A-D</b>: -3.00 mm, -3.12 mm, -3.24 mm and -3.36 mm from bregma) and medullary dorsal reticular nucleus (DRt) (<b>E-H</b>: -13.92 mm, -14.04 mm, -14.16 and -14.28 mm from bregma) of SHAM (light dots; n = 7) and ARTH (dark dots; n = 5). …”
  4. 504
  5. 505
  6. 506
  7. 507
  8. 508
  9. 509
  10. 510
  11. 511
  12. 512
  13. 513

    B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

    Published 2025
    “…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”
  14. 514
  15. 515

    Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

    Published 2012
    “…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”
  16. 516

    Dopamine decreases the refractive power in the lens periphery. by J. Marcus Schartau (365288)

    Published 2013
    “…<p>(A) The mean ΔBCD curves describe the difference between the treated and untreated lenses from all animals (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0010402#s4" target="_blank">Methods and Materials</a>). …”
  17. 517
  18. 518
  19. 519
  20. 520